Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1661 News Items found MSK Kids Patient Reunited With Nurse on Today Show Tuesday, May 10, 2022 To celebrate National Nurses Week (May 6 to May 12), Today Show anchor Hoda Kotb interviewed MSK Nurse Cassie DeMatteis about an extraordinary relationship with one of her littlest patients. Clinical Trial Nurses: Key to Patient Care and Innovation Monday, May 9, 2022 For RuthAnn (“Ruthy”) Gordon, Director of Clinical Trials Nursing, some of the best days are when the FDA approves a drug from a clinical trial that she worked on. It’s happened to her four times. How Cognitive Behavior Therapy for Insomnia (CBT-I) Helps People With Cancer Sleep Better Monday, May 9, 2022 Learn about how cognitive behavioral therapy for insomnia (CBT-I) helps people with cancer improve sleep. Taking Giant Leaps: Luis Alberto Diaz, Jr., MD, of Memorial Sloan Kettering Cancer Center Inducted into Giants of Cancer Care® Class of 2022 Monday, May 9, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science. Vik Gill: The Uplifter Friday, May 6, 2022 Most children face pressures growing up — including from their parents and peers. Vik Gill wrestled with circumstances “that may sound more familiar to any child of first-generation immigrants. FDA Approves Immunotherapy That’s Less Intensive for People With Lymphoma Thursday, May 5, 2022 In April 2022, the FDA approved the immunotherapy drug axicabtagene ciloleucel (Yescarta®) for the treatment of diffuse large B cell lymphoma earlier in the course of disease. Retired teacher and basketball coach Joe Crimi is one of the patients who benefited from this treatment. ‘People Want To Be Heard’: Meet MSK’s New Chief Nurse, Tracy Gosselin Thursday, May 5, 2022 Memorial Sloan Kettering's new chief nurse Tracy Gosselin says she was taken by surprise when she was asked to consider MSK's top nursing job. Cannabis and Cancer: What We Know So Far Wednesday, May 4, 2022 Dr. Diane Reidy-Lagunes discusses cannabis and cancer with MSK’s Director of Pediatric Integrated Medicine, Dr. Nirupa Raghunathan, and cancer survivor and winner of TV’s “Survivor: Africa”, Ethan Zohn. How To Talk to Family and Friends About a Cancer Diagnosis Linked to HPV Tuesday, May 3, 2022 An MSK expert gives advice on how to talk to family and friends about a cancer diagnosis linked to HPV, which some people find particularly challenging. In the Lab New Immunotherapy Approach Targets a Commonly Mutated ‘Driver’ Protein Unique to Cancer Cells Friday, April 29, 2022 Investigators at MSK are developing new immunotherapy treatments that rely on engineering T cells to recognize mutated proteins that are unique to cancer. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next MSK Experts Present Research at Bone Marrow Transplant and Cellular Therapy Meeting